2017
DOI: 10.22186/jyi.33.4.77-82
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic Potential of Optogenetic Treatment for Individuals with Multiple Sclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 29 publications
0
2
0
Order By: Relevance
“…(Ordaz et al, 2017, Gibson et al, 2014 Research also suggests that Oligodendrocyte precursor cells (OPCs) could be optogenetically modulated to tackle MS, furthermore, astrocytes expressing ChR2 could be stimulated with light to reduce inflammation and increase the protection of neurons. (Koussy & Jadavji, 2017)…”
Section: Multiple Sclerosismentioning
confidence: 99%
“…(Ordaz et al, 2017, Gibson et al, 2014 Research also suggests that Oligodendrocyte precursor cells (OPCs) could be optogenetically modulated to tackle MS, furthermore, astrocytes expressing ChR2 could be stimulated with light to reduce inflammation and increase the protection of neurons. (Koussy & Jadavji, 2017)…”
Section: Multiple Sclerosismentioning
confidence: 99%
“…Related information about the therapeutic potential of photostimulation in the treatment of MS-related symptoms can be found in the review coordinated by El Koussy and Jadavji. 49…”
Section: Msmentioning
confidence: 99%
“…Moreover, it has been shown that optogenetics can be effective in attenuating MS‐associated signs and symptoms like tremors, 45 visual learning and memory impairment, 46 visual dysfunction, 47 and bladder and bowel impairment 48 by controlling specific pathways involved in them. Related information about the therapeutic potential of photostimulation in the treatment of MS‐related symptoms can be found in the review coordinated by El Koussy and Jadavji 49 …”
Section: Neurobiologymentioning
confidence: 99%